Nipocalimab Reference: HY-P99037 Nipocalimab (M281) is a fully human, recombinant, aglycosylated IgG1 monoclonal antibody. Nipocalimab is a human deglycosylated IgG1 anti-FcRn monoclonal antibody that binds with picomolar affinity to Fc receptor (FcRn) at both endosomal pH 6.0 and extracellular pH 7.6.
Atezolizumab Reference: HY-P9904 Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.
Detumomab Reference: HY-P99851 Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma. Detumomab can be used in the research of cancers such as non-Hodgkin's lymphoma (NHL).
Melredableukin alfa Reference: HY-P99728 Melredableukin alfa (RO-7049665) is a fusion protein that consists of a human IgG1-κ fused to a mutated human interleukin 2 (IL2 mutein) via a peptide linker. Melredableukin alfa can be used for the research of autoimmune hepatitis and ulcerative colitis.
Phospho FAK Antibody Panel Reference: ARG30203 Phospho FAK antibody; Phospho Focal adhesion kinase antibody; FAK antibody; FAK phospho (Tyr925) antibody; FAK phospho (Tyr397) antibody; FAK phospho (Tyr576 / Tyr577) antibody
Amlitelimab Reference: HY-P99434 Alvircept sudotox is an anti-OX40 Ligand (OX40L) monoclonal antibody (mAb). Alvircept sudotox inhibits OX40-OX40L interaction, and can be used in the research of atopic dermatitis.
Garadacimab Reference: HY-P99631 Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research.